Popular
TBPH · Medicine & biotech · U.S.

Theravance Biopharma

Sells Yupelri, an inhaled medicine for the lung disease COPD.

Company Health

We couldn’t find yearly financial reports from this company with the SEC.

Who owns it

None of the 23 funds we follow reported owning Theravance Biopharma in their latest reports. Laughing Water sold all their shares in their latest report.
bought lately
owns it
doesn’t own it
Didn’t report owning it: Whale Rock, Appaloosa, Melqart, Coatue, D1 Capital, Light Street, Lone Pine, Third Point, TCI, Pershing Square, Duquesne, Himalaya Capital, Greenlight, Giverny Capital, Fundsmith, Semper Augustus, Akre, Laughing Water
Their letters don’t mention it: Arquitos, Alluvial, Bireme, Kingdom Capital, Saga Partners
From each fund’s latest 13F report (Jun 30, 2026). Funds that don’t file one: from their own letters.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works